Hobamine has claimed the spotlight in the field of cellular health this past year, and TSI Group eagerly anticipates the developments in 2024. Hobamine, TSI Group’s latest ingredient breakthrough, has garnered recognition as one of the standout discoveries of the year. As we take pride in reflecting on the past year, we eagerly anticipate exploring new studies and findings that await on the horizon. But first, let’s revisit some notable highlights from 2023.     New Study Shows 2-HOBA has a Promising Impact on Immune Health In a study funded by the NIH and published in the journal Inflammation, it

In Nutraceuticals World an article Immune Health Remains a Top Priority, Even as Many Move on from Covid, highlights the importance of immune health and how new supplement formulas offer great value to consumers. Despite a 4.3% decline in sales for immune health supplements in the last year, the category remains relevant. The decline is slowing, and experts believe it won’t plummet to the levels seen after the pandemic’s peak. One significant challenge faced by manufacturers, vendors, and retailers is dealing with overstock issues as they stocked up on immune products during the pandemic. However, this overstock situation has opened

In Nutritional Outlook, industry leaders give their expert advice on the trends that are driving the cellular health market. The cellular health industry continues to grow with more and more ingredients coming to the forefront.  As this category evolves, it’s hard for consumers to navigate the market.  Brands need to step up their game to educate consumers on the science behind these ingredients. New Developments in Cellular Health “Aging research has evolved in recent years,” says Aileen Stocks, president of wellness brands at Nestlé Health Science. “Researchers now know there is a time-related decline of several cellular mechanisms that often